Lansing Street Advisors’s Medtronic MDT Stock Holding History

Lansing Street Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$45.2K	Hold	513	–	–	0.03%	142
2023 Q1	$41.4K	Sell	513 -23	-4%	-$1.88K	0.03%	154
2022 Q4	$41.7K	Buy	536 +23	+4%	+$1.86K	0.03%	168
2022 Q3	$41K	Hold	513	–	–	0.03%	140
2022 Q2	$46K	Hold	513	–	–	0.04%	127
2022 Q1	$58K	Buy	+513	New	+$54.2K	0.04%	123

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Lansing Street Advisors's MDT Position: Q2 2023 in Review

Lansing Street Advisors held its Medtronic (MDT) position steady in Q2 2023 at 513 shares worth $45.2K. The position accounts for 0.03% of the portfolio, ranked #142.

Lansing Street Advisors first reported a position in MDT in Q1 2022 and has held it in 6 quarters since. The position peaked at $58K in Q1 2022. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

Lansing Street Advisors held 513 shares of Medtronic worth $45.2K as of Q2 2023.
Lansing Street Advisors left its Medtronic share count unchanged in Q2 2023.
Medtronic made up 0.03% of Lansing Street Advisors's portfolio in Q2 2023, its #142 holding.
Lansing Street Advisors first reported a position in Medtronic in Q1 2022 and has held it in 6 quarters since.
Lansing Street Advisors's Medtronic position peaked at $58K in Q1 2022.
2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Lansing Street Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.